APA (7th ed.) Citation

Wingert, J., Meinhardt, E., Sasipong, N., Pott, M., Lederer, C., de la Torre, C., . . . Schlegel, P. (2024). Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin. Biochemical Pharmacology, 225, N.PAG. https://doi.org/10.1016/j.bcp.2024.116305

Chicago Style (17th ed.) Citation

Wingert, J., et al. "Cardiomyocyte-specific RXFP1 Overexpression Protects Against Pressure Overload-induced Cardiac Dysfunction Independently of Relaxin." Biochemical Pharmacology 225 (2024): N.PAG. https://doi.org/10.1016/j.bcp.2024.116305.

MLA (9th ed.) Citation

Wingert, J., et al. "Cardiomyocyte-specific RXFP1 Overexpression Protects Against Pressure Overload-induced Cardiac Dysfunction Independently of Relaxin." Biochemical Pharmacology, vol. 225, 2024, p. N.PAG, https://doi.org/10.1016/j.bcp.2024.116305.